TransMolecular, Inc.: An Oncology Focused Biotechnology Company
 
Pursuing Cures for Cancer Through Targeted Therapy
   


medical advisory board

company overview | management | board of directors | investors | medical advisory board

 

Lewis C. Cantley, Ph.D.
Professor of System Biology, Harvard Medical School
Director, Beth Israel Deaconess Cancer Center
Chief, Div. of Signal Transduction, Beth Israel Deaconess Medical Center
Boston, MA

Patricia A. D’Amore, Ph.D.
Professor, Department of Ophthalmology and Pathology
Harvard Medical School
Boston, MA

John K. Erban, MD
Director of Clinical Programs
Gillette Center for Breast Cancer
Massachusetts General Hospital
Boston, MA

William C. Hahn, MD, Ph.D.
Associate Professor of Medicine – Harvard Medical School
Department of Medical Oncology – Dana-Farber Cancer Institute
Boston, MA

Jay S. Loeffler, MD, F.A.C.R.
Chief, Department of Radiation Oncology
Herman & Joan Suit Professor of Radiation Oncology
Harvard Medical School
Massachusetts General Hospital
Boston, MA

Ralph R. Weichselbaum, MD

Daniel K. Ludwig Professor and Chairman
Department of Radiation and Cellular Oncology
Director, Ludwig Center for Metastasis Research
The University of Chicago
Chicago, IL.

 

 

company overview | management | board of directors | investors | medical advisory board | product pipeline | publications & abstracts | completed glioma clinical trials | ongoing clinical trials | future directions | currently recruiting | media relations | press releases | abstracts & articles | in the news | events | research & development | additional resources | advancing targeted cancer therapy | clinical trials | disease information | news | about glioma | glioma | other primary brain tumors | metastatic brain tumors | contact us | careers | site map